Akoya Biosciences Inc (AKYA)
2.20
-0.06
(-2.65%)
USD |
NASDAQ |
Jun 13, 16:00
2.20
0.00 (0.00%)
Pre-Market: 20:00
Akoya Biosciences Cash and Short Term Investments (Quarterly): 61.58M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 61.58M |
December 31, 2023 | 83.12M |
September 30, 2023 | 78.60M |
June 30, 2023 | 93.33M |
March 31, 2023 | 60.25M |
December 31, 2022 | 81.22M |
September 30, 2022 | 81.70M |
Date | Value |
---|---|
June 30, 2022 | 87.61M |
March 31, 2022 | 93.94M |
December 31, 2021 | 113.08M |
September 30, 2021 | 120.15M |
June 30, 2021 | 135.46M |
March 31, 2021 | 11.69M |
December 31, 2020 | 17.01M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
11.69M
Minimum
Mar 2021
135.46M
Maximum
Jun 2021
79.91M
Average
82.41M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Bruker Corp | 340.10M |
Azenta Inc | 821.71M |
Harvard Bioscience Inc | 4.255M |
Bionano Genomics Inc | 52.77M |
Singular Genomics Systems Inc | 150.74M |